In addition to enabling enhanced surveillance and access to preventive strategies, early awareness of a germline pathogenic variant in BRCA1/2 or PALB2 vastly influences surgical decision making when a patient is diagnosed with breast cancer. This evidence concerns the gene PALB2 and breast cancer.